Lourdes Dericks-Cortes

Hamburg, HH 20146, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

An Overview of Cellular and Molecular Determinants Regulating Chemoresistance in Pleural Mesothelioma.

An Overview of Cellular and Molecular Determinants Regulating Chemoresistance in Pleural Mesothelioma.

Journal: Cancers

Published: January 02, 2025

Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight.

Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight.

Journal: Cancers

Published: September 30, 2021

Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases.

Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases.

Journal: Cancers

Published: September 04, 2020

Author Correction: The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges.

Author Correction: The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 13, 2019

The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges.

The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: June 03, 2019

CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.

CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.

Journal: Respiratory research

Published: February 15, 2017

Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines.

Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines.

Journal: Stem cell research & therapy

Published: September 02, 2015

A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids.

A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids.

Journal: Lab on a chip

Published: February 06, 2014

Suppression of OCT4B enhances sensitivity of lung adenocarcinoma A549 cells to cisplatin via increased apoptosis.

Suppression of OCT4B enhances sensitivity of lung adenocarcinoma A549 cells to cisplatin via increased apoptosis.

Journal: Anticancer research

Published: December 11, 2013

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.

Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.

Journal: BMC cancer

Published: November 26, 2013

High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.

High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: April 25, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026